Navigation Links
Catheter repair of mitral valve improves heart size, symptoms
Date:4/1/2008

CHICAGO, Ill. (April 1, 2008) A catheter-mounted device that acts like a clothespin to clip together the flaps of a leaky heart valve is not only reducing the abnormal backflow of blood from the left ventricle to the left atrium, it is helping to shrink the enlarged, overworked heart and relieving symptoms of fluid overloadall without open-chest surgery. These are the one-year findings in a small group of patients enrolled in the Endovascular Valve Edge-to-Edge Repair Study (EVEREST), which is evaluating the use of the MitraClip for the treatment of mitral regurgitation (MR).

The sub-analysis is being reported today in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for practicing cardiovascular interventionalists sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) in partnership with the American College of Cardiology (ACC).

One trouble with mitral regurgitation is that the heart has to work harder, and over time, it dilates and enlarges, said James Hermiller, MD, director of the interventional fellowship at St. Vincent Heart Center of Indiana in Indianapolis. Demonstrating that the left ventricular enlargement is actually reversing itself is important objective evidence that the heart is responding favorably. It confirms that theres something real here.

Mounted on the end of a catheter, the MitraClip is threaded through the femoral vein in the groin and into the right atrium. A needle puncture in the wall separating the upper chambers of the heart enables the catheter to pass into the left atrium, where the clip is opened up like a clothespin. It is then passed through the mitral valve into the left ventricle. When the heart contracts, the flaps of the mitral valve are grasped by the clip, which is then closed, securing the edges of the valve flaps together at their centers. The result is a bow-tie-shaped opening that permits blood flow from the left atrium to the left ventricle during relaxation of the heart, and enables the valve flaps to close more effectively during contraction, rather than allowing leakage of blood backward into the left atrium.

The study by Dr. Hermiller and his colleagues focused on 23 patients treated at 15 medical centers either during the EVEREST I study or during the roll-in phase of the ongoing EVEREST II study, which is comparing MitraClip therapy to open-chest surgery. All of the patients in the new analysis had functional MR, which results not from a defect in the valve leaflets but from enlargement of the valve opening as a result of heart attack or heart failure. Of the quarter-million people newly diagnosed with mitral regurgitation in the United States each year, as many as two-thirds have the functional form, but it hasnt been clear whether the MitraClip would work as well in functional MR as in degenerative MR.

Before the procedure, all patients had moderately severe or severe mitral regurgitation, and 83 percent of patients had heart failure ranked as New York Heart Association (NYHA) functional class III or IV, which is characterized by lung congestion, shortness of breath, fatigue, swelling of the legs, and difficulty with light-to-moderate physical activity. After the procedure, mitral regurgitation was mild to modest in 19 of 22 patients (83 percent) treated with the MitraClip.

After one year, 12 patients had completed follow-up and had matched data from both baseline and follow-up. Ten of the 12 patients (83 percent) continued to have only mild to modest mitral regurgitation and nine of 12 (75 percent) continued to enjoy an improvement in symptoms and daily function of at least one NYHA class. In addition, heart size was significantly smaller. For example, the left ventricular internal diameter during relaxation, or diastole, fell from an average of 6.0 cm at baseline to 5.4 cm at 12 months (p=0.037), and left ventricular end-diastolic volume fell from an average of 208 mL at baseline to 178 mL at 12 months (p=0.037).

This is a small study, but it demonstrates a proof of principle that the MitraClip can reduce mitral regurgitation and improve heart function in patients with functional MR, Dr. Hermiller said. These findings are promising and interesting, but clearly we need a lot more data.

Dr. Hermiller will present the results of this study on Tuesday, April 1 at 10:30 a.m. CDT in the Grand Ballroom, S100.


'/>"/>

Contact: Kathy Boyd David
pr@scai.org
717-422-1181
Weber Shandwick Worldwide
Source:Eurekalert

Related medicine news :

1. Led by Cardiovascular Applications, Double Digit Growth Expected for Catheter Sales
2. St. Davids Medical Center First in Texas to Implement Visually Guided Catheter Ablation for Atrial Fibrillation
3. Balloon catheter-based sinus surgery radiation exposure very low, safe
4. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
5. Catheter chaos: Hospitals lag in preventing common infection
6. Massive necrosis after trans-catheter treatment is more common in the presence of tumor capsule
7. Catheter angiography may be an unnecessary follow-up to CT angiography
8. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
9. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
10. Wildcat Power Cord Repairs Cruciate Ligament in Dairy Cows Knee
11. Correction: Evalve Announces CE Mark Approval of the Worlds First Percutaneous Valve Repair System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
Breaking Medicine Technology: